Insulin therapy and colorectal adenomas in patients with diabetes mellitus

Cancer Epidemiology Biomarkers and Prevention

Volumn 21, Issue 10, 2012, Pages 1833-1840

  Wong, Patricia ^a,b   Weiner, Mark G ^b   Hwang, Wei Ting ^b   Yang, Yu Xiao ^a,b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RISK; COLONOSCOPY; COLORECTAL ADENOMA; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; HUMAN; INSULIN TREATMENT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT DURATION; TUMOR LOCALIZATION;

ADENOMA; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INTESTINAL POLYPS; MALE; MIDDLE AGED; RISK FACTORS; TIME FACTORS;

EID: 84867299922     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-0771     Document Type: Article

References (40)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29.
2. Sugarbaker J, Gunderson L, Wittes R.Colorectal cancer. In: De Vita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practices of oncology. Philadelphia: JB Lippincott; 1985: p 800-803.
3. Zauber AG, Winawer SJ, O'Brien MJ, Lansdorp-Vogelaar I, van Ballegooijen M, Hankey BF, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 2012;366:687-96.
4. Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology 2003;124:544-60. (Pubitemid 36169269)
5. Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 2005;97:1679-87. (Pubitemid 41672234)
6. Giovannucci E. Insulin and colon cancer. Cancer Causes Control 1995;6:164-79.
7. Sandhu MS, Dunger DB, Giovannucci EL. Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. J Natl Cancer Inst 2002;94:972-80. (Pubitemid 34814726)
8. Koohestani N, Tran TT, Lee W, Wolever TM, Bruce WR. Insulin resistance and promotion of aberrant crypt foci in the colons of rats on a high-fat diet. Nutr Cancer 1997;29:69-76. (Pubitemid 27508127)
9. Corpet DE, Jacquinet C, Peiffer G, Tache S. Insulin injections promote the growth of aberrant crypt foci in the colon of rats. Nutr Cancer 1997;27:316-20. (Pubitemid 27161531)
10. Tran TT, Medline A, Bruce WR. Insulin promotion of colon tumors in rats. Cancer Epidemiol Biomarkers Prev 1996;5:1013-5. (Pubitemid 26415875)
11. Schoen RE, Tangen CM, Kuller LH, Burke GL, Cushman M, Tracy RP, et al. Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst 1999;91:1147-54. (Pubitemid 29330553)
12. Kaaks R, Toniolo P,Akhmedkhanov A, Lukanova A, Biessy C, Dechaud H, et al. Serum C-peptide, insulin-like growth factor (IGF)-I, IGFbinding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 2000;92:1592-600.
13. Genuth S. Insulin use in NIDDM. Diabetes Care 1990;13:1240-64.
14. Yang YX, Hennessy S, Lewis JD. Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology 2004;127:1044-50. (Pubitemid 39345873)
15. Chung YW, Han DS, Park KH, Eun CS, Yoo KS, Park CK, et al. Insulin therapy and colorectal adenoma risk among patients with type 2 diabetes mellitus: a case-control study in Korea. Dis Colon Rectum 2008;51:593-7.
16. Wright A, Burden AC, Paisey RB, Cull CA, Holman RRGroup UKPDS. Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57). Diabetes Care 2002;25:330-6. (Pubitemid 41079631)
17. Rex DK, Lehman GA, Ulbright TM, Smith JJ, Pound DC, Hawes RH, et al. Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: influence of age, gender, and family history. Am J Gastroenterol 1993;88:825-31. (Pubitemid 23181863)
18. Makar GA, Weiner MG, Kimmel SE, Bennett D, Burke A, Yang YX, et al. Incidence and predictors of abnormal liver associated enzymes in patients with atrial fibrillation in a routine clinical care population. Pharmacoepidemiol Drug Saf 2007;17:43-51. (Pubitemid 351166617)
19. Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol 1989;129:125-37. (Pubitemid 19030705)
20. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 2001;131(11 Suppl):3109S-20S. (Pubitemid 33070788)
21. LeRoith D, Baserga R, Helman L, Roberts CT Jr. Insulin-like growth factors and cancer. Ann Intern Med 1995;122:54-9.
22. Ritter MM, Richter WO, Schwandt P. Acromegaly and colon cancer. Ann Intern Med 1987;106:636-7.
23. Renehan AG, Painter JE, Atkin WS, Potten CS, Shalet SM, O'Dwyer ST. High-risk colorectal adenomas and serum insulin-like growth factors. Br J Surg 2001;88:107-13. (Pubitemid 32066068)
24. Teramukai S, Rohan T, Lee K-Y, Eguchi H, Oda T, Kono S. Insulin-like growth factor (IGF)-I, IGF-binding protein-3 and colorectal adenomas in Japanese men. Jpn J Cancer Res 2002;93:1187-94. (Pubitemid 36032980)
25. Renehan AG, Painter JE, O'Halloran D, Atkin WS, Potten CS, O'Dwyer ST, et al. Circulating insulin-like growth factor II and colorectal adenomas. J Clin Endocrinol Metab 2000;85:3402-8.
26. Schoen RE, Weissfeld JL, Kuller LH, Thaete FL, Evans RW, Hayes RB, et al. Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps. Gastroenterology 2005;129:464-75. (Pubitemid 41096634)
27. Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 1999;281:2005-12. (Pubitemid 29254858)
28. American Diabetes A. Standards of medical care in diabetes-2007. Diabetes Care 2007;30 Suppl 1:S4-41.
29. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995;28:103-17.
30. Anonymous. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-53.
31. Garvey WT, Olefsky JM, Griffin J, Hamman RF, Kolterman OG. The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. Diabetes 1985;34:222-34. (Pubitemid 15134779)
32. Fearon ER, Vogelstein B.A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
33. Limburg PJ, Anderson KE, Johnson TW, Jacobs DR Jr, Lazovich D, Hong CP, et al. Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev 2005;14:133-7. (Pubitemid 40165293)
34. Hu FB, Manson JE, Liu S, Hunter D, Colditz GA, Michels KB, et al. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 1999;91:542-7. (Pubitemid 29157063)
35. Tavani A, Bravi F, Bosetti C, Franceschi S, Levi F, Talamini R, et al. Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev 2005;14:2277.
36. Tomiyama R, Kinjo F, Hokama A, Saito A. Relationship between diabetes mellitus and the site of colorectal cancer. Am J Gastroenterol 2003;98:944-5. (Pubitemid 36576338)
37. LeMarchand L, Wilkens LR, Kolonel LN, Hankin JH, Lyu LC. Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer. Cancer Research 1997;57:4787-94. (Pubitemid 27468985)
38. Weiderpass E, Gridley G, Nyren O, Ekbom A, Persson I, Adami HO. Diabetes mellitus and risk of large bowel cancer. J Natl Cancer Inst 1997;89:660-1. (Pubitemid 27200500)
39. Yang YX, Habel LA, Capra AM, Achacoso NS, Quesenberry CP Jr, Ferrara A, et al. Serial glycosylated hemoglobin levels and risk of colorectal neoplasia among patients with type 2 diabetes mellitus. Cancer Epidemiol Biomarkers Prev 2010;19:3027-36.
40. Lewis JD, Capra AM, Achacoso NS, Ferrara A, Levin TR, Quesenberry CP Jr, et al. Medical therapy for diabetes is associated with increased use of lower endoscopy. Pharmacoepidemiol Drug Saf 2007;16:1195-202. (Pubitemid 350120644)